About Alkira Bio
Alkira Bio is a company based in Melbourne (Australia) founded in 2024. Alkira Bio offers products and services including LASEREDD Platform. Alkira Bio operates in a competitive market with competitors including AbSci, Antiverse, LabGenius, Ordaos and Orbit Discovery, among others.
- Headquarter Melbourne, Australia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alkira Bio
Alkira Bio offers a comprehensive portfolio of products and services, including LASEREDD Platform.
Platform for discovering antibodies targeting complex membrane proteins
Funding Insights of Alkira Bio
Investors in Alkira Bio
Alkira Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Curie.Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Curie.Bio is involved in an unspecified business activity.
|
Locked | Locked | Locked |
Investor details for Alkira Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Alkira Bio
Investment portfolio details for Alkira Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Alkira Bio
Detailed financials for Alkira Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Alkira Bio Comparisons
Peer comparison for Alkira Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Alkira Bio
Alkira Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, Antiverse, LabGenius, Ordaos and Orbit Discovery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
An AI platform for antibody drug discovery is provided.
|
|
| Locked | Locked | Locked |
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
|
|
| Locked | Locked | Locked |
AI accelerator provided for biomedical research and drug discovery.
|
|
| Locked | Locked | Locked |
Drug discovery platform developed using peptide display engine.
|
|
| Locked | Locked | Locked |
An AI-based platform for antibody discovery and therapeutics is developed.
|
Detailed competitors of Alkira Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Alkira Bio
Complete news archive for Alkira Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alkira Bio
Alkira Bio was founded in 2024.
Alkira Bio is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Alkira Bio was founded in 2024 in Melbourne, Australia, within the biotechnology sector. Therapeutic antibodies directed at complex membrane proteins, particularly G protein-coupled receptors, are developed using the LASEREDD platform. This technology enables discovery processes for antibody-based therapeutics. Operations are centered on advancing treatments for challenging protein targets, with a focus on research and development activities in the Australian biotech landscape.
Alkira Bio offers LASEREDD Platform.
Alkira Bio has 1 investor. Key investors include Curie.Bio.